153 Results

People

  1. Aghajanian
    Aghajanian
  2. Chi
    Chi
  3. Barakat
    Barakat
  4. Spriggs
    Spriggs
  5. Abu-Rustum
    Abu-Rustum
  6. Seshan
    Seshan
  7. O'Reilly
    O'Reilly
  8. Riely
    Riely
  9. Rosenberg
    Rosenberg
  10. Sabbatini
    Sabbatini

Groups

  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (47)
  4. Gynecology Disease Management Team (30)
  5. Survivorship Research (27)
  6. Epidemiology and Biostatistics (25)
  7. Biostatistics Service (23)
  8. Gynecologic Medicine Service (21)
  9. GDMT, Medicine (20)
  10. Thoracic Oncology (19)
  1. "platinum"
Formats
  1. Journal Article (141)
  2. Review (8)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Guidelines (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (47)
  4. Gynecology Disease Management Team (30)
  5. Survivorship Research (27)
  6. Epidemiology and Biostatistics (25)

More Groups

People
  1. Carol Aghajanian (16)
  2. Dennis Chi (13)
  3. David Spriggs (12)
  4. Richard Barakat (12)
  5. Paul Sabbatini (10)
  6. Dean Bajorin (8)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (11)
  4. 2022 (2)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Gynecologic Oncology (20)
  2. Journal of Clinical Oncology (16)
  3. Journal of Thoracic Oncology (9)
  4. Cancer (8)
  5. The Oncologist (7)
  6. International Journal of Radiation Oncology, Biology, Physics (5)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. American Society of Clinical Oncology (17)
  3. Wiley Blackwell (11)
  4. Elsevier Science, Inc. (9)
  5. Oxford University Press (9)
  6. Lippincott Williams & Wilkins (8)

More Publishers

Results (153)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes and molecular correlates of sotorasib efficacy in patients with pretreated KRAS G12C-mutated non-small-cell lung cancer: 2-Year analysis of CodeBreaK 100
    Journal Article

    Dy, G. K.; Govindan, R.; Velcheti, V.; Falchook, G. S.; Italiano, A.; Wolf, J.; Sacher, A. G.; Takahashi, T.; Ramalingam, S. S.; Dooms, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pancreatic cancer: BRCA targeted therapy and beyond
    Review

    Keane, F.; O’Connor, C. A.; Park, W.; Seufferlein, T.; O’Reilly, E. M.
    Cancers (2023)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity: Analysis of axicabtagene ciloleucel versus standard of care in patients with relapsed/refractory large B cell lymphoma
    Journal Article

    Kersten, M. J.; Qiao, Y.; Shah, R.; Solem, C.; Snider, J. T.; To, C.; Cheng, P.; Spooner, C.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: A NRG oncology randomized study
    Journal Article

    Tewari, K. S.; Sill, M. W.; Birrer, M. J.; Penson, R. T.; Huang, H.; Moore, D. H.; Ramondetta, L. M.; Landrum, L. M.; Oaknin, A.; Reid, T. J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
    Review

    Yang, J. C. H.; Zhou, C.; Jänne, P. A.; Ramalingam, S. S.; Kim, T. M.; Riely, G. J.; Spira, A. I.; Piotrowska, Z.; Mekhail, T.; Garcia Campelo, M. R.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2
    Guidelines

    Owen, D. H.; Singh, N.; Ismaila, N.; Blanchard, E.; Celano, P.; Florez, N.; Jain, D.; Leighl, N. B.; Mamdani, H.; Masters, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma
    Journal Article

    O'Malley, D. M.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Health-related quality of life of patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin after platinum and PD-1/PD-L1 inhibitor therapy: Results from cohort 1 of the phase 2 EV-201 clinical trial
    Journal Article

    McGregor, B.; O'Donnell, P. H.; Balar, A.; Petrylak, D.; Rosenberg, J.; Yu, E. Y.; Quinn, D. I.; Heath, E. I.; Campbell, M.; Hepp, Z.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Health-related quality of life in cancer survivors with chemotherapy-induced peripheral neuropathy: A randomized clinical trial
    Journal Article

    Bao, T.; Baser, R.; Chen, C.; Weitzman, M.; Zhang, Y. L.; Seluzicki, C.; Li, Q. S.; Piulson, L.; Zhi, W. I.
    The Oncologist (2021)

    Fulltext@MSK | Save